MODELING THE LONG-TERM NEUTRALIZING ANTIBODY PERSISTENCE IN ADULTS AFTER ONE DOSE OF LIVE ATTENUATED JAPANESE ENCEPHALITIS CHIMERIC VIRUS VACCINE

被引:0
|
作者
Desai, Kamal [1 ]
Coudeville, Laurent [1 ]
Bailleux, Fabrice [1 ]
机构
[1] Sanofi Pasteur SA, Lyon, France
来源
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
1050
引用
收藏
页码:313 / 314
页数:2
相关论文
共 50 条
  • [41] Live rubella virus vaccine long-term persistence as an antigenic trigger of cutaneous granulomas in patients with primary immunodeficiency
    Bodemer, C.
    Sauvage, V.
    Mahlaoui, N.
    Cheval, J.
    Couderc, T.
    Leclerc-Mercier, S.
    Debre, M.
    Pellier, I.
    Gagnieur, L.
    Fraitag, S.
    Fischer, A.
    Blanche, S.
    Lecuit, M.
    Eloit, M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (10) : O656 - O663
  • [42] Long-term Antibody Persistence After Hepatitis E Virus Infection and Vaccination in Dongtai, China
    Kmush, Brittany L.
    Yu, Huan
    Huang, Shoujie
    Zhang, Xuefang
    Wu, Ting
    Nelson, Kenrad E.
    Labrigue, Alain B.
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (04):
  • [43] Post-Marketing Surveillance of Adverse Events Following Vaccination with the Live-Attenuated Japanese Encephalitis Chimeric Virus Vaccine (Imojev®) in South Korea, 2015–2019
    Hee Soo Kim
    Yongho Oh
    Joanna Korejwo
    Valérie Bosch Castells
    Kuhyun Yang
    Infectious Diseases and Therapy, 2020, 9 : 589 - 598
  • [44] Response letter: "Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules"
    Costantini, Marco
    Callegaro, Andrea
    Beran, Jiri
    Berlaimont, Valerie
    Galgani, Ilaria
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (09) : 2282 - 2284
  • [45] Long-term antibody persistence after vaccination with a 2-dose Havrix™ (inactivated hepatitis A vaccine): 20 years of observed data, and long-term model-based predictions
    Theeten, Heidi
    Van Herck, Koen
    Van Der Meeren, Olivier
    Crasta, Priya
    Van Damme, Pierre
    Hens, Niel
    VACCINE, 2015, 33 (42) : 5723 - 5727
  • [46] Long-term immunogenicity after single and booster dose of a live attenuated hepatitis A vaccine: Results from 8-year follow-up
    Wang, Xuan-Yi
    Xu, Zhi-Yi
    Ma, Jing-Chen
    von Seidlein, Lorenz
    Zhang, Yong
    Hao, Zhi-Yong
    Han, Oak Pil
    Zhang, Ying-Lin
    Tian, Mei-Ying
    Ouyang, Pei-Ying
    Zhang, Zhi-Yong
    han, Cg-Quan Han
    Xing, Zhan-Chun
    Chen, Ji-Chao
    VACCINE, 2007, 25 (03) : 446 - 449
  • [47] COMPARISON OF LONG-TERM SYSTEMIC AND SECRETORY ANTIBODY-RESPONSES IN CHILDREN GIVEN LIVE, ATTENUATED, OR INACTIVATED INFLUENZA-A VACCINE
    JOHNSON, PR
    FELDMAN, S
    THOMPSON, JM
    MAHONEY, JD
    WRIGHT, PF
    JOURNAL OF MEDICAL VIROLOGY, 1985, 17 (04) : 325 - 335
  • [48] Long-term persistence of SARS-CoV-2 neutralizing antibody responses after infection and estimates of the duration of protection
    Lau, Eric H. Y.
    Hui, David S. C.
    Tsang, Owen T. Y.
    Chan, Wai-Hung
    Kwan, Mike Y. W.
    Chiu, Susan S.
    Cheng, Samuel M. S.
    Ko, Ronald Lw
    Li, John K. C.
    Chaothai, Sara
    Tsang, Chi H.
    Poon, Leo L. M.
    Peiris, Malik
    ECLINICALMEDICINE, 2021, 41
  • [49] Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials
    Torresi, Joseph
    McCarthy, Karen
    Feroldi, Emmanuel
    Meric, Claude
    VACCINE, 2010, 28 (50) : 7993 - 8000
  • [50] Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur® Adults
    Plentz, Annelie
    Jilg, Wolfgang
    Schwarz, Tino F.
    Kuhr, Hans B.
    Zent, Olaf
    VACCINE, 2009, 27 (06) : 853 - 856